Membrane-bound phosphodiesterases in rat myocardium

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 9, 1996, Pages 962-964

  Kaasik, Allen ^b   Ohisalo, Jorma J ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF TARTU   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP PHOSPHODIESTERASE; ISOENZYME; MEMBRANE ENZYME; PHOSPHODIESTERASE; ROLIPRAM; SIGUAZODAN;

ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; HEART MUSCLE; HEART MUSCLE FIBER MEMBRANE; IMMUNOBLOTTING; ION EXCHANGE CHROMATOGRAPHY; NONHUMAN; RAT; TEMPERATURE SENSITIVITY;

EID: 0029994212     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb06012.x     Document Type: Article

References (14)

1. Beavo, J. A., Reifsnyder, D. H. (1990) Primary sequences of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol. Sci. 11: 150-155
2. Davis, C. W., Daly, J. W. (1979) A simple direct assay of 3′,5′ -cyclic nucleotide phosphodiesterase activity based on the use of polyacrylamide-boronate affinity gel chromatography. J. Cyclic Nucleotide Res. 5: 65-74
3. Kaasik, A., Elomaa, V-V., Seppet, E. K., Ohisalo, J. J. (1994) Low particulate type IV phosphodiesterase activity in hypothyroid rat atria. J. Mol. Cell. Cardiol. 26: 1587-1592
4. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275
5. Manganiello, V. C., Murata, T., Taira, M., Belfrage, P., Degerman, E. (1995) Diversity in cyclic nucleotide phosphodiesterase isoenzyme families. Arch. Biochem. Biophys. 322: 1-13
6. Murray, K. J., England, P. J., Hallam, T.J., Maguire, J., Moores, K., Reeves, M. L., Simpson, A. W., Rink, T. J. (1990) The effects of siguazodan, a selective phosphodiesterase inhibitor, on human platelet function. Br. J. Pharmacol. 99: 612-616
7. Ohisalo, J. J. (1987) Regulatory functions of adenosine. Med Biol 65: 181-191
8. Ohisalo, J. J., Vikman, H-L., Ranta, S., Houslay, M. D., Milligan, G. (1989) Adipocyte plasma membrane Gi and Gs in insulinopenic diabetic patiens. Biochem. J. 264: 289-292
9. Reeves, M. L., Gristwood, R. W., Leigh, B. K., England, P. J. (1987) SK&F 98346, a potent inotropic agent, is a selective inhibitor of type III PDE activity from several tissues. Br. J. Pharmacol. 92: 773P
10. Shahid, M., Wilson, M., Nicholson, C. D., Marshall, R. J. (1990) Species-dependent differences in the properties of particulate cyclic nucleotide phosphodiesterase from rat and rabbit ventricular myocardium. J. Pharm. Pharmacol. 42: 283-284
11. Tang, K. M., Jang, E. K., Haslam, R. J. (1994) Photoaffinity labelling of cyclic GMP-inhibited phosphodiesterase (PDE III) in human and rat platelets and rat tissues: effects of phosphodiesterase inhibitors. Eur. J. Pharmacol. 268: 105-114
12. Torphy, T. J., Undem, B. J., Cieslinski, L. B., Luttmann, M. A., Reeves, M. L., Hay, D. W. (1993). Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle. J. Pharmacol. Exp. Ther. 265: 1213-1223
13. Thompson, W. J. (1991) Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function. Pharmacol. Ther. 51: 13-33
14. Whalin, M. E., Garrett, R. L., Thomson, W. J., Strada, S. J. (1989) Correlation of cell-free brain cyclic nucleotide phosphodiesterase activities to cyclic AMP decay in intact brain slices. Second Messengers Phosphoproteins 12: 311-325